Liver health study in adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with Type 1 diabetes.
- You must NOT have Type 2 diabetes.
- You must NOT be taking steroid medications (like prednisone).
- You must NOT drink alcohol heavily or for a long time.
- You must NOT have other liver diseases (like hepatitis) or serious liver problems (like cirrhosis or liver tumors).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common fatty liver disease is in people with type 1 diabetes and what might increase the risk. By joining, you could help doctors understand and better manage liver health for people with type 1 diabetes.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
This study looks at fat buildup in the liver (fatty liver disease) in people with and without HIV. It uses blood tests to understand the liver's fat content and how it relates to HIV, which may help improve future care.
This study looks at how the liver responds to sugar given through a vein in obese patients with and without a fatty liver condition called MASLD. It may help doctors understand why some people develop liver problems from sugar and fat.
This study looks at whether a simple blood test (FIB-4) can help detect liver scarring in people with obesity. It may help doctors identify liver problems earlier.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.